Profiles

Keywords
Last Name
Institution
 Back to Profile

Martin Hertl

Concepts (328)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Liver Transplantation
30
2018
114
5.960
 Why?
Liver
14
2019
214
2.610
 Why?
Kidney Transplantation
10
2021
141
2.130
 Why?
Living Donors
10
2011
16
1.650
 Why?
Portal Vein
7
2018
47
1.510
 Why?
Hepatectomy
7
2018
65
1.400
 Why?
Carcinoma, Hepatocellular
6
2021
41
1.370
 Why?
Liver Neoplasms
6
2021
117
1.270
 Why?
Galactosyltransferases
3
2013
3
0.900
 Why?
Liver Failure, Acute
4
2018
5
0.900
 Why?
Gallstones
1
2021
7
0.880
 Why?
Pancreatitis
1
2021
29
0.870
 Why?
Transplantation, Heterologous
3
2016
26
0.750
 Why?
Organ Preservation
4
2011
10
0.730
 Why?
Swine
10
2018
117
0.730
 Why?
Hepatomegaly
1
2018
6
0.720
 Why?
Humans
59
2022
31481
0.720
 Why?
Tissue Donors
3
2021
79
0.640
 Why?
Liver Regeneration
4
2017
27
0.630
 Why?
Kidney Failure, Chronic
7
2020
176
0.610
 Why?
Male
41
2021
17583
0.560
 Why?
Retrospective Studies
16
2022
3591
0.550
 Why?
Neuroendocrine Tumors
3
2019
48
0.520
 Why?
Middle Aged
30
2020
11209
0.510
 Why?
Bile Ducts
2
2011
14
0.500
 Why?
Constriction, Pathologic
2
2019
39
0.490
 Why?
BK Virus
1
2013
12
0.490
 Why?
Carcinoma, Transitional Cell
1
2013
17
0.480
 Why?
Animals
16
2021
5312
0.480
 Why?
Perfusion
2
2011
23
0.470
 Why?
Kidney Neoplasms
1
2013
78
0.460
 Why?
Hypertension, Malignant
1
2012
2
0.450
 Why?
Protein S Deficiency
1
2011
2
0.450
 Why?
Organ Transplantation
2
2021
43
0.430
 Why?
Arteriovenous Shunt, Surgical
2
2022
22
0.430
 Why?
Hypercholesterolemia
1
2011
39
0.430
 Why?
Mesentery
1
2011
6
0.420
 Why?
Ligation
4
2018
37
0.420
 Why?
Peritoneal Neoplasms
1
2011
7
0.420
 Why?
Carcinoid Tumor
1
2011
21
0.420
 Why?
Female
30
2021
18253
0.410
 Why?
Pancreas
2
2021
36
0.400
 Why?
Decision Support Techniques
1
2010
55
0.400
 Why?
Kidney
4
2021
210
0.390
 Why?
Intestines
1
2011
114
0.390
 Why?
Endothelial Cells
1
2010
67
0.390
 Why?
Adrenal Cortex Neoplasms
2
2020
13
0.390
 Why?
Adrenocortical Carcinoma
2
2020
12
0.390
 Why?
Cholagogues and Choleretics
2
1999
2
0.380
 Why?
Taurochenodeoxycholic Acid
2
1999
3
0.380
 Why?
Reperfusion Injury
2
1999
9
0.380
 Why?
Postoperative Complications
10
2022
1083
0.370
 Why?
Pancreatic Neoplasms
3
2019
181
0.350
 Why?
Food Hypersensitivity
1
2009
51
0.350
 Why?
Bile Duct Neoplasms
2
2005
10
0.350
 Why?
Hepatopulmonary Syndrome
1
2008
1
0.350
 Why?
Treatment Outcome
15
2022
3910
0.340
 Why?
Hepatitis C
2
2008
68
0.340
 Why?
Gastrointestinal Stromal Tumors
1
2008
30
0.340
 Why?
Informed Consent
2
2005
24
0.330
 Why?
Tissue and Organ Harvesting
3
2004
25
0.330
 Why?
Gynecomastia
1
2007
1
0.330
 Why?
Carcinoma, Intraductal, Noninfiltrating
1
2007
15
0.330
 Why?
Incidental Findings
1
2007
20
0.320
 Why?
Breast Neoplasms
2
2011
442
0.310
 Why?
Graft Survival
8
2016
111
0.300
 Why?
Biliary Tract Diseases
2
2019
7
0.300
 Why?
Neoplasm Staging
4
2019
481
0.300
 Why?
Tissue and Organ Procurement
2
2003
37
0.300
 Why?
Coccidioides
1
2006
3
0.300
 Why?
Survival Rate
6
2020
465
0.300
 Why?
Coccidioidomycosis
1
2006
8
0.300
 Why?
Time Factors
8
2022
1902
0.290
 Why?
Liver Diseases
2
2017
40
0.290
 Why?
Registries
1
2007
214
0.280
 Why?
Directed Tissue Donation
1
2005
1
0.280
 Why?
Donor Selection
1
2005
1
0.280
 Why?
Physician-Patient Relations
1
2005
47
0.270
 Why?
Adult
14
2020
9779
0.260
 Why?
Cholangiopancreatography, Endoscopic Retrograde
2
2021
10
0.260
 Why?
Hepatitis B, Chronic
1
2003
10
0.260
 Why?
Postoperative Hemorrhage
2
2014
31
0.250
 Why?
Biliary Tract Surgical Procedures
2
2019
4
0.250
 Why?
Communication
1
2005
129
0.250
 Why?
Papio hamadryas
2
2013
2
0.250
 Why?
Swine, Miniature
2
2013
9
0.250
 Why?
Liver Function Tests
4
2015
33
0.240
 Why?
Venous Thrombosis
2
2019
51
0.240
 Why?
Incidence
3
2021
829
0.240
 Why?
Liver Failure
2
2018
14
0.230
 Why?
Gastroparesis
1
2022
4
0.230
 Why?
Arteriovenous Fistula
1
2022
13
0.230
 Why?
Aneurysm
1
2022
20
0.230
 Why?
Random Allocation
3
2018
164
0.220
 Why?
Pancreaticoduodenectomy
1
2022
38
0.220
 Why?
Urogenital Abnormalities
1
2021
6
0.220
 Why?
Pancreas Transplantation
1
2021
16
0.220
 Why?
Infertility, Female
1
2021
26
0.220
 Why?
Specialization
1
2001
21
0.220
 Why?
Cholecystectomy
1
2021
19
0.220
 Why?
Hospitals, University
1
2001
46
0.220
 Why?
Raffinose
1
2001
2
0.220
 Why?
Ursodeoxycholic Acid
1
2001
2
0.220
 Why?
Organ Preservation Solutions
1
2001
2
0.220
 Why?
Immunoglobulin G
2
2013
134
0.220
 Why?
Glutathione
1
2001
31
0.220
 Why?
Graft vs Host Disease
1
2021
55
0.220
 Why?
Allopurinol
1
2001
7
0.220
 Why?
Organ Size
2
2018
122
0.210
 Why?
Adenosine
1
2001
15
0.210
 Why?
Xenograft Model Antitumor Assays
1
2021
31
0.210
 Why?
Transplant Recipients
1
2021
19
0.210
 Why?
Bone Marrow Transplantation
2
2013
40
0.210
 Why?
Ultrasonography
3
2018
210
0.210
 Why?
Follow-Up Studies
5
2020
2028
0.210
 Why?
Surgical Instruments
1
2020
30
0.210
 Why?
Renal Dialysis
4
2022
117
0.200
 Why?
Gene Expression Regulation, Neoplastic
1
2021
136
0.200
 Why?
Antineoplastic Agents
2
2021
274
0.200
 Why?
Insulin
1
2001
116
0.200
 Why?
Hepatic Veins
2
2018
9
0.200
 Why?
Adrenalectomy
1
2019
6
0.190
 Why?
Health Care Costs
1
2020
81
0.190
 Why?
Jejunostomy
1
2019
8
0.190
 Why?
Prognosis
4
2020
1028
0.190
 Why?
Suture Techniques
1
2020
138
0.190
 Why?
Pancreatectomy
1
2019
18
0.190
 Why?
Chemotherapy, Adjuvant
1
2019
109
0.190
 Why?
Breast Implants
3
2011
8
0.190
 Why?
Abdominal Neoplasms
1
2019
13
0.180
 Why?
Heat Stroke
1
2018
1
0.180
 Why?
Intestinal Neoplasms
1
2018
13
0.180
 Why?
Digestive System Surgical Procedures
1
2018
27
0.180
 Why?
Patient Compliance
1
2020
200
0.180
 Why?
Hospitalization
1
2021
359
0.170
 Why?
Papio
3
2016
12
0.170
 Why?
Pulmonary Embolism
1
2019
57
0.170
 Why?
Stomach Neoplasms
1
2018
40
0.170
 Why?
Child, Preschool
2
2013
786
0.170
 Why?
Venous Thromboembolism
1
2019
53
0.170
 Why?
Hypertrophy
1
2017
20
0.160
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2018
81
0.160
 Why?
Neovascularization, Physiologic
1
2017
29
0.160
 Why?
Vascular Patency
4
2022
31
0.160
 Why?
Aged
11
2020
10295
0.160
 Why?
Prostatic Neoplasms
1
2017
122
0.150
 Why?
Gene Knockout Techniques
2
2013
12
0.150
 Why?
Patient Selection
4
2019
264
0.150
 Why?
Thrombocytopenia
2
2014
32
0.150
 Why?
Graft Occlusion, Vascular
2
2022
29
0.140
 Why?
Liver Cirrhosis
2
2014
60
0.140
 Why?
Tobacco Use Disorder
1
2015
20
0.140
 Why?
Jaundice, Obstructive
1
2015
1
0.140
 Why?
Kaplan-Meier Estimate
2
2019
230
0.140
 Why?
Cysts
1
2015
21
0.140
 Why?
Disease Models, Animal
1
2018
832
0.140
 Why?
Biopsy
2
2013
283
0.140
 Why?
Graft Rejection
4
2020
84
0.130
 Why?
Antibodies, Heterophile
1
2013
1
0.130
 Why?
Heterografts
1
2013
18
0.130
 Why?
Heart Transplantation
1
2014
50
0.130
 Why?
Bilirubin
2
2011
14
0.130
 Why?
Heart-Assist Devices
1
2014
31
0.120
 Why?
Creatinine
1
2013
59
0.120
 Why?
Hematoma
1
2013
24
0.120
 Why?
Immunosuppressive Agents
3
2020
163
0.120
 Why?
Ureterostomy
1
2012
1
0.120
 Why?
Cystostomy
1
2012
4
0.120
 Why?
Polytetrafluoroethylene
2
2011
8
0.120
 Why?
Magnetic Resonance Imaging
3
2015
1273
0.110
 Why?
Ureter
1
2012
25
0.110
 Why?
Blood Vessel Prosthesis
2
2011
27
0.110
 Why?
Protein S
1
2011
2
0.110
 Why?
Hepatic Encephalopathy
1
2012
6
0.110
 Why?
Intracranial Hypertension
1
2012
13
0.110
 Why?
Warm Ischemia
1
2011
2
0.110
 Why?
Bile
1
2011
6
0.110
 Why?
Neoplasm Metastasis
2
2018
129
0.110
 Why?
Intracranial Pressure
1
2012
24
0.110
 Why?
Alkaline Phosphatase
1
2011
16
0.110
 Why?
Breast Implantation
1
2011
4
0.110
 Why?
Hepatitis, Autoimmune
1
2011
9
0.110
 Why?
Databases, Factual
3
2019
391
0.110
 Why?
Monitoring, Intraoperative
1
2012
43
0.110
 Why?
Mastectomy
1
2011
30
0.110
 Why?
Hemodynamics
1
2011
103
0.110
 Why?
Endoscopy, Digestive System
1
2011
10
0.110
 Why?
Intestinal Obstruction
1
2011
14
0.100
 Why?
Oxygen
1
2011
94
0.100
 Why?
Waiting Lists
2
2014
18
0.100
 Why?
Energy Metabolism
1
2011
82
0.100
 Why?
Gastrointestinal Hemorrhage
1
2011
29
0.100
 Why?
Complement C3a
1
2010
3
0.100
 Why?
Complement Activation
1
2010
14
0.100
 Why?
Immunoglobulin M
1
2010
21
0.100
 Why?
Cytotoxicity, Immunologic
1
2010
35
0.100
 Why?
End Stage Liver Disease
1
2010
17
0.100
 Why?
Transplantation, Autologous
1
2011
223
0.100
 Why?
Tissue Engineering
1
2010
50
0.100
 Why?
Rats
3
2016
966
0.100
 Why?
Tomography, X-Ray Computed
2
2015
891
0.100
 Why?
Anaphylaxis
1
2009
9
0.090
 Why?
Fatal Outcome
1
2009
75
0.090
 Why?
Nephrectomy
1
2009
44
0.090
 Why?
Risk Factors
3
2022
2664
0.090
 Why?
Neoplasm Recurrence, Local
1
2010
236
0.090
 Why?
Survival Analysis
3
2018
379
0.090
 Why?
Models, Animal
2
2016
149
0.090
 Why?
Hemophilia A
1
2008
42
0.090
 Why?
Transplantation Chimera
1
2008
3
0.090
 Why?
Transplantation Tolerance
1
2008
4
0.090
 Why?
Young Adult
2
2020
2277
0.090
 Why?
Cadaver
1
2009
356
0.080
 Why?
United States
3
2020
2539
0.080
 Why?
Multivariate Analysis
2
2019
390
0.080
 Why?
Colonoscopy
1
2008
88
0.080
 Why?
Rats, Wistar
2
2017
64
0.080
 Why?
Reoperation
1
2012
938
0.080
 Why?
New England
1
2006
4
0.070
 Why?
Cholangitis, Sclerosing
1
2006
4
0.070
 Why?
Hepatoblastoma
1
2005
1
0.070
 Why?
Blood Coagulation Factors
2
2016
19
0.070
 Why?
Cholangiocarcinoma
1
2005
8
0.070
 Why?
Hemangioendothelioma, Epithelioid
1
2005
7
0.070
 Why?
Cystic Duct
1
2005
1
0.070
 Why?
Coercion
1
2005
7
0.070
 Why?
Cholestasis
1
2005
9
0.070
 Why?
Social Values
1
2005
11
0.070
 Why?
Interview, Psychological
1
2005
45
0.070
 Why?
Postoperative Period
2
2019
295
0.070
 Why?
Liver Circulation
2
2017
6
0.070
 Why?
Medical Oncology
1
2005
39
0.070
 Why?
Animals, Genetically Modified
2
2014
18
0.070
 Why?
Referral and Consultation
1
2005
99
0.060
 Why?
Adenoma
1
2005
63
0.060
 Why?
Combined Modality Therapy
2
2019
456
0.060
 Why?
Anastomosis, Surgical
2
2019
56
0.060
 Why?
Contrast Media
1
2004
144
0.060
 Why?
Decision Making
1
2005
232
0.060
 Why?
Pancreatic Fistula
1
2022
3
0.060
 Why?
Steroids
1
2022
30
0.060
 Why?
Uterus
1
2021
27
0.060
 Why?
Hysterectomy
1
2021
24
0.050
 Why?
Naphthoquinones
1
2021
6
0.050
 Why?
Rats, Inbred Lew
1
2001
13
0.050
 Why?
Benzofurans
1
2021
8
0.050
 Why?
Aniline Compounds
1
2021
40
0.050
 Why?
Sulfonamides
1
2021
64
0.050
 Why?
In Vitro Techniques
1
2001
248
0.050
 Why?
Cost Savings
1
2020
38
0.050
 Why?
Cost-Benefit Analysis
1
2020
153
0.050
 Why?
Mitotane
1
2019
3
0.050
 Why?
Quality Improvement
1
2022
173
0.050
 Why?
Bile Acids and Salts
1
1999
14
0.050
 Why?
Diagnosis, Differential
2
2013
467
0.050
 Why?
Lymphatic Metastasis
1
2020
107
0.050
 Why?
Tumor Burden
1
2019
42
0.050
 Why?
Infusions, Intravenous
1
1999
89
0.050
 Why?
Disease-Free Survival
1
2019
241
0.050
 Why?
Blood Coagulation Disorders
1
2019
15
0.050
 Why?
Cyclosporine
1
1999
19
0.050
 Why?
Serum Albumin
1
2019
28
0.050
 Why?
Analysis of Variance
1
1999
364
0.040
 Why?
Operative Time
1
2019
97
0.040
 Why?
Proportional Hazards Models
1
2019
390
0.040
 Why?
Prostate-Specific Antigen
1
2017
17
0.040
 Why?
Portal Pressure
1
2017
5
0.040
 Why?
Fungi
1
1997
6
0.040
 Why?
Adolescent
2
2020
2667
0.040
 Why?
Dose-Response Relationship, Drug
1
2018
512
0.040
 Why?
Anticoagulants
1
2019
151
0.040
 Why?
Hyperplasia
1
2017
26
0.040
 Why?
Bacteria
1
1997
74
0.040
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2019
405
0.040
 Why?
Cell Hypoxia
1
2016
17
0.040
 Why?
Practice Guidelines as Topic
1
2019
389
0.040
 Why?
Paecilomyces
1
1995
3
0.040
 Why?
Mice
1
2021
1894
0.040
 Why?
Policy
1
2015
4
0.040
 Why?
Brain
1
2006
1655
0.040
 Why?
Mycoses
1
1995
23
0.040
 Why?
Chicago
1
2018
955
0.030
 Why?
Smoking Cessation
1
2015
53
0.030
 Why?
Blood Transfusion
1
2014
68
0.030
 Why?
Smoking
1
2015
202
0.030
 Why?
Cardiovascular Diseases
1
2018
410
0.030
 Why?
Risk Assessment
1
2017
806
0.030
 Why?
Lymphocyte Culture Test, Mixed
1
2013
9
0.030
 Why?
Attitude of Health Personnel
1
2015
181
0.030
 Why?
Immunity, Cellular
1
2013
68
0.030
 Why?
Stents
1
2015
155
0.030
 Why?
Prosthesis-Related Infections
1
1995
209
0.030
 Why?
Cohort Studies
1
2018
2014
0.030
 Why?
Massachusetts
1
2011
21
0.030
 Why?
Biocompatible Materials
1
2011
112
0.030
 Why?
Hepatocytes
1
2010
13
0.030
 Why?
Extracellular Matrix
1
2010
92
0.020
 Why?
Aged, 80 and over
1
2020
5234
0.020
 Why?
Patient Education as Topic
1
2011
192
0.020
 Why?
Angiography
1
2009
53
0.020
 Why?
Factor VIII
1
2008
27
0.020
 Why?
Blood Loss, Surgical
1
2008
71
0.020
 Why?
Hemorrhage
1
2008
90
0.020
 Why?
Hepatocyte Nuclear Factor 3-alpha
1
2008
1
0.020
 Why?
Transplantation Immunology
1
2008
5
0.020
 Why?
Histocompatibility Testing
1
2008
6
0.020
 Why?
Granzymes
1
2008
8
0.020
 Why?
Transplantation Conditioning
1
2008
40
0.020
 Why?
Hepatitis C, Chronic
1
2008
84
0.020
 Why?
Laparoscopy
1
2009
190
0.020
 Why?
RNA, Messenger
1
2008
371
0.020
 Why?
Transplantation, Homologous
1
2008
292
0.020
 Why?
T-Lymphocytes
1
2008
242
0.020
 Why?
Sodium Chloride
2
1997
44
0.020
 Why?
Vena Cava, Inferior
1
2006
14
0.020
 Why?
Prospective Studies
1
2011
1934
0.020
 Why?
Syndrome
1
2005
105
0.020
 Why?
Biliary Tract
1
2004
3
0.020
 Why?
Cholangiopancreatography, Magnetic Resonance
1
2004
4
0.020
 Why?
Hepatic Artery
1
2004
3
0.020
 Why?
Magnetic Resonance Angiography
1
2004
51
0.020
 Why?
Preoperative Care
1
2004
146
0.020
 Why?
Imaging, Three-Dimensional
1
2004
233
0.010
 Why?
Liver Cirrhosis, Alcoholic
1
2002
7
0.010
 Why?
Forecasting
1
2001
134
0.010
 Why?
Silicone Elastomers
1
1997
3
0.010
 Why?
Culture Media
1
1997
44
0.010
 Why?
Rabbits
1
1997
326
0.010
 Why?
Hertl's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (328) concept(s)
_
Co-Authors Expand Description
See all (23) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department